Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Gene Therapy Assets of Klotho Available

it is partnering with AAVnerGene Inc. (AAVnerGene), a Rockville, MD-based innovation-driven biotech renowned for its transformative technologies in AAV manufacturing and tissue-targeted delivery. Dr. Joseph Sinkule, the CEO of KLTO stated "we...

Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market

high-value markets with practical, differentiated solutions,” said Jeff Yordon, Co-Founder and CEO of Avenacy. “The vial format of Avenacy’s product supports safe handling, and the unique 5-pack presentation helps providers manage high-cost...

Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) as a Sterile Injectable Solution

team is committed to growing our business and being among the leading animal health pharmaceutical companies. For more information please visit, www.cronuspharmausa.com

Made Scientific and Sentinel BioTherapeutics Announce a Strategic Manufacturing Partnership to Advance the Phase I/II Allogeneic ePP Encapsulated Cell Therapy Program

localized immune-modulating therapies for tumors that are unresponsive to current treatments. Sentinel's lead platform delivers potent cytokines, such as IL-2, via encapsulated allogeneic cell-based protein producers (ePPs) designed for...

Sun Pharma Announces the Launch of LEQSELVI™ (deuruxolitinib) in the United States for Treating Severe Alopecia Areata

compared to 4.3% with placebo), and nasopharyngitis (8.1% as compared to 6.7% with placebo). Please see full Prescribing Information Including BOXED WARNING and Medication Guide and see below for Important Safety Information.1 Sun Pharma is...

TrueMed Partners with Alliance Pharmaceuticals Ltd to Combat Sophisticated Counterfeits Using AI-Powered Authentication

Pharmaceuticals Ltd to go beyond traditional investigations by: Scanning product complaint images using TrueMed's AI platform to detect minute inconsistencies invisible to the human eye Generating immediate, digital evidence reports without the...

Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as the First Treatment for Dry Eye Disease Associated with MGD—A Breakthrough in Ophthalmology

is dievini Hopp BioTech holding GmbH & Co. KG, an active investor in Life and Health Sciences companies. For more information please visit, www.novaliq.com.

Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 Begins with First Patient Dosed

ADCs to treat cancer and autoimmune diseases. DualityBio has successfully built several cutting-edge ADC technology platforms with global intellectual property rights. Leveraging a robust pipeline, DualityBio is conducting multiple global clinical...

With Fifth NovaSeq X Plus System in Europe, Novogene Europe Expands Sequencing Capabilities

spend and data quality to drive scientific breakthroughs." The NovaSeq X Plus – Illumina's most advanced sequencing platform – generates up to 16 terabases of data in 48 hours, enabling critical applications including whole-genome sequencing,...

Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model: Tinnitus Research

examined in a Europe-wide Phase-2-study in patients for its effectiveness in sudden hearing loss and tinnitus. For more information please visit, www.audiocure.com

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com.

Seraphina Therapeutics Announces C15:0 Reverses Key Aspects of Cellular Fragility Syndrome in a Second Model

if cells do not have adequate C15:0 levels, they can become fragile, resulting in Cellular Fragility Syndrome and a new form of cell death, called ferroptosis. In turn, this leads to accelerated aging and impaired red blood cell, liver, metabolic,...

Neurocrine Biosciences Presents New Post-Hoc Data from the KINECT®-HD Study, Demonstrating a Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea

endpoint. The UHDRS is a comprehensive clinical rating scale developed by the Huntington Study Group to provide a uniform assessment of the clinical features and course of HD. It is comprised of motor, cognitive, behavioral, and functional...

Innovent Announces Approval from China's NMPA for Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist, for Chronic Weight Management

to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com

To Redefine Specialty Care, Craft Telemedicine Launches with a Human-Centered Platform

Craft Telemedicine today announced the official launch of its innovative telemedicine platform that eliminates subscription models and empowers patients with unprecedented choice and transparency in their healthcare decisions. Unlike traditional...

Alafair Biosciences Announces Enrollment of First Patient in Multi-Center Study Testing VersaWrap® Tendon Protector for Achilles Repair

Designed with and conducted by investigators across multiple sites in the United States, the study will assess the performance of VersaWrap in reducing postoperative complications such as tendon tethering. "Tendon injuries, especially those...

With New Offerings Like MIC+B12 Injections, Metformin Combinations, and More, Shed Expands Its Weight Management Support

MIC+B12 injections that support metabolic health and energy production, as well as two new oral combination therapies: Metformin + Naltrexone + Topiramate and Naltrexone + Bupropion. Together, these offerings create a powerful portfolio of weight...

enGene’s Detalimogene Receives RMAT Designation from the FDA, Opening the Path for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

to treat NMIBC though the non-viral stimulation of a local immune response in the bladder, presenting a potentially transformative option for patients who otherwise face limited choices beyond radical cystectomy. About Non-Muscle Invasive Bladder...

Fierce CRO Award Winner Crown Bioscience Named for Excellence in Global Operations.

exceptional achievements and innovations by Contract Research Organizations, recognizing CROs demonstrating outstanding performance, innovation, and leadership in delivering high-quality research and development services. The awards emphasize the...

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

High-Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE: WAT) today announced the release of the Alliance iS HPLC System Software version 2.0, a significant advancement that delivers comprehensive, end-to-end...